Centrient Pharmaceuticals has announced that the Delhi High Court in India has granted an injunction against China’s Sinopharm Weiqida Pharmaceutical blocking the export, import and sale into India of its amoxicillin trihydrate active pharmaceutical ingredient (API) in any form.
Sinopharm Weiqida was also found to be prima facie in contempt of the Delhi High Court’s original preliminary injunction order,...






